Pulmonary hypertension (PH) is a complex and often misunderstood condition characterized by elevated pulmonary arterial pressure and secondary right ventricular failure. This article aims to provide a comprehensive understanding of the fundamentals of PH, including its pathophysiology, diagnosis, and management strategies.
PH is typically defined by a mean pulmonary arterial pressure of 25mmHg at rest. This increased pressure is often the result of vasoconstriction, vascular remodeling, and thrombosis in situ within the pulmonary vasculature. It is crucial to understand that PH is not a disease in itself, but rather a hemodynamic and pathophysiological state that can be secondary to a variety of conditions.
Diagnosing PH can be challenging due to its nonspecific symptoms. It is typically suspected in patients with unexplained dyspnea or in those with diseases known to predispose to PH. Diagnostic tools include echocardiography, right heart catheterization, and various imaging studies. The gold standard for diagnosis remains right heart catheterization.
Management of PH is multifaceted and depends on the underlying cause. General measures include oxygen therapy, diuretics, and anticoagulation. Specific treatments targeting the pulmonary vasculature include endothelin receptor antagonists, phosphodiesterase-5 inhibitors, and prostacyclin analogues. In severe cases, lung transplantation may be considered.
In conclusion, PH is a complex condition requiring a thorough understanding of its pathophysiology, diagnosis, and management. By enhancing our understanding of these fundamentals, healthcare professionals can better diagnose and manage patients with PH, ultimately improving patient outcomes.
1.
Combo Therapy Boosts Early CML Response but Not Long Term
2.
PNH With Extravascular Hemolysis Approves Factor D Inhibitor.
3.
In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.
4.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
5.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
1.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
2.
Decoding Hamartomas: Understanding Their Causes and Symptoms
3.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
Efficient Management of First line ALK-rearranged NSCLC
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation